Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.95 USD | +9.20% | +5.56% | -80.63% |
Mar. 15 | Maxim Group Adjusts Quoin Pharmaceuticals Price Target to $4 From $15, Maintains Buy Rating | MT |
Mar. 14 | Quoin Pharmaceuticals Seeks M&A Opportunities | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-80.63% | 3.5M | |
+9.30% | 46.03B | |
+52.73% | 44.55B | |
+7.15% | 40.8B | |
-8.78% | 28.25B | |
+18.68% | 27.71B | |
-21.92% | 18.82B | |
+14.62% | 13.91B | |
+31.85% | 12.43B | |
-8.77% | 11.06B |
- Stock
- Equities
- Stock Quoin Pharmaceuticals, Ltd. - Nasdaq
- News Quoin Pharmaceuticals, Ltd.
- Sector Update: Health Care Stocks Decline in Premarket Thursday